Molecular and cellular processes disrupted in the early postnatal Down syndrome prefrontal cortex

Area of Science:

• Neuroscience
• Genetics
• Developmental Biology

Background:

• Down syndrome is a genetic disorder causing intellectual disability and developmental delays.
• The precise molecular mechanisms behind neurodevelopmental impairments in Down syndrome are not fully understood.
• Early postnatal development is crucial for brain maturation, synaptogenesis, and neuroimmune interactions.

Purpose of the Study:

• To investigate the molecular underpinnings of neurodevelopmental impairments in the Down syndrome prefrontal cortex during early postnatal development.
• To create a molecular atlas of Down syndrome neuropathology at a critical developmental stage.
• To identify potential therapeutic targets for Down syndrome-associated neuroinflammation.

Main Methods:

• Single-nucleus multiomic sequencing was employed to simultaneously profile gene expression and chromatin accessibility.
• The study focused on the prefrontal cortex during early postnatal development in Down syndrome.
• Analysis identified dysregulated pathways, cellular deficits, and neuroinflammatory signatures.

Main Results:

• Widespread dysregulation of chromatin accessibility and gene expression was observed in the Down syndrome brain.
• Deficits were identified in metabolic and synaptic pathways, and oligodendrocyte lineage progression.
• A pronounced neuroinflammatory signature was a key finding, indicating altered neuroimmune interactions.

Conclusions:

• The study provides a molecular atlas of Down syndrome neuropathology during early brain development.
• Convergent neurodevelopmental and neurodegenerative pathways are highlighted.
• Findings inform potential targeted therapies for Down syndrome-associated neuroinflammation.